Exercise training in patients with ventricular assist devices: a review of the evidence and practical advice. A position paper from the Committee on Exercise Physiology and Training and the Committee of Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology.


Journal

European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595

Informations de publication

Date de publication:
01 2019
Historique:
received: 21 02 2018
revised: 06 08 2018
accepted: 26 08 2018
pubmed: 27 11 2018
medline: 22 5 2019
entrez: 27 11 2018
Statut: ppublish

Résumé

Exercise training (ET) and secondary prevention measures in cardiovascular disease aim to stimulate early physical activity and to facilitate recovery and improve health behaviours. ET has also been proposed for heart failure patients with a ventricular assist device (VAD), to help recovery in the patient's functional capacity. However, the existing evidence in support of ET in these patients remains limited. After a review of current knowledge on the causes of the persistence of limitation in exercise capacity in VAD recipients, and concerning the benefit of ET in VAD patients, the Heart Failure Association of the European Society of Cardiology has developed the present document to provide practical advice on implementing ET. This includes appropriate screening to avoid complications and then starting with early mobilisation, ET prescription is individualised to meet the patient's needs. Finally, gaps in our knowledge are discussed.

Identifiants

pubmed: 30474896
doi: 10.1002/ejhf.1352
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-13

Informations de copyright

© 2018 The Authors. European Journal of Heart Failure © 2018 European Society of Cardiology.

Auteurs

Stamatis Adamopoulos (S)

Heart Failure and Heart Transplantation Unit, Onassis Cardiac Surgery Center, Athens, Greece.

Ugo Corrà (U)

Cardiology Department, Istituti Clinici Scientifici Maugeri, Centro Medico di Riabilitazione di Veruno, Novara, Italy.

Ioannis D Laoutaris (ID)

Heart Failure and Heart Transplantation Unit, Onassis Cardiac Surgery Center, Athens, Greece.

Massimo Pistono (M)

Cardiology Department, Istituti Clinici Scientifici Maugeri, Centro Medico di Riabilitazione di Veruno, Novara, Italy.

Pier Giuseppe Agostoni (PG)

Centro Cardiologico Monzino, IRCCS, Milan, Italy; Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan, Milan, Italy.

Andrew J S Coats (AJS)

Department of Cardiology, IRCCS San Raffaele Pisana, Rome, Italy.

Maria G Crespo Leiro (MG)

Heart Failure and Transplant Unit, Complexo Hospitalario Universitario A Coruña (CHUAC), INIBIC, CIBERCV, UDC, La Coruña, Spain.

Justien Cornelis (J)

Faculty of Medicine and Health Sciences, Translational Pathophysiological Research, University of Antwerp, Antwerp, Belgium.

Constantinos H Davos (CH)

Cardiovascular Research Laboratory, Biomedical Research Foundation, Academy of Athens, Athens, Greece.

Gerasimos Filippatos (G)

Heart Failure Unit, Attikon University Hospital, Athens, Greece.

Lars H Lund (LH)

Department of Medicine, Karolinska Institutet and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.

Tiny Jaarsma (T)

Department of Nursing, University of Linköping, Linköping, Sweden.

Frank Ruschitzka (F)

Department of Cardiology, University Heart Center, Zürich, Switzerland.

Petar M Seferovic (PM)

University of Belgrade School of Medicine, Belgrade, Serbia.

Jean-Paul Schmid (JP)

Chefarzt Kardiologie, Klinik Barmelweid AG, Barmelweid, Switzerland.

Maurizio Volterrani (M)

Department of Cardiology, IRCCS San Raffaele Pisana, Rome, Italy.

Massimo F Piepoli (MF)

Heart Failure Unit, Cardiac Department, Guglielmo da Saliceto Hospital, Piacenza, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH